2022 Volvo XC40 Inscription
2.0 L • 4 • 248 hp • 4×4 • AT
YV4162UL2N2665168
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • USAA
Key included
Yes
Docs
Good
History
1 record
Drive
2.0 L • 4 • 248 hp • 4×4 • AT
Odometer
15,813 mi ≈ 25,448 km
Primary damage
Front end
Docs
MD • Salvage <75% Damage
Extra
Auction
VIN
YV4162UL2N2665168
Lot number
88087495
Copart
Sale status
Sold
Seller type
Insurance
Seller
USAA
Location
Washington Dc, DC
Description
Fuel type
Gasoline
Body color
Blue
Body type
SUV
Generation
Gen I
Trim
Inscription
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
2022 Volvo XC40 Inscription • 2.0 L • 4 cyl • 248 hp • 4×4 • Automatic • Copart Lot: 88087495 • VIN: YV4162UL2N2665168
Find out more about this 2022 Volvo XC40 Inscription, available at the Copart salvage car auction as lot 88087495 in Washington Dc, DC. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 15,813 mi. This Blue Volvo XC40 SUV is equipped with Gasoline 2.0 L engine, 4×4 drivetrain, Automatic transmission. Check the vehicle history report for YV4162UL2N2665168 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
